Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 21 April 2008

European Journal of Endocrinology 2008;159:41.

DOI: 10.1530/EJE-08-0072
Copyright © 2008 by European Society of Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
EJE-08-0072v1
159/1/41    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reis, J.
Right arrow Articles by Miller, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reis, J.
Right arrow Articles by Miller, E.

RESEARCH

Relation of 25-Hydroxyvitamin D and Parathyroid Hormone Levels with Metabolic Syndrome among US Adults

Jared Reis, Denise von Muhlen and Edgar Miller

J Reis, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States
D von Muhlen, Department of Family and Preventive Medicine, University of California, San Diego, San Diego, United States
E Miller, Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, United States

Correspondence: Jared Reis, Email: jreis{at}jhsph.edu

Abstract

Objective: Previous research on the combined association of 25-hydroxyvitamin D [25(OH)D] and parathyroid hormone (PTH) with metabolic syndrome may have been limited by restricted age variability and lack of representation of the general population. This study examined the combined association of 25(OH)D and PTH with Adult Treatment Panel III-defined MetSyn among a nationally representative sample of US adults.

Design and Methods: This population-based cross-sectional study included 834 men and 820 women aged >20 years without diagnosed diabetes who completed a physical examination as part of the 2003-2004 US National Health and Nutrition Examination Survey.

Results: After adjusting for age, sex, race/ethnicity, income, lifestyle factors, total calcium, and energy intake, the odds ratio (OR) for MetSyn in the highest quintile of 25(OH)D (median 88.0 nmol/L) compared with the lowest quintile (median 26.8 nmol/L) was 0.27 (0.15, 0.46; p trend<0.001). This relation was unchanged after additional adjustment for PTH level (OR, 0.26; 0.15, 0.44; p trend<0.001) and did not differ by sex (p interaction 0.6) or age (< or > 50 years) (p interaction 0.2). In contrast, the multivariable-adjusted odds for MetSyn increased with increasing PTH among older men (p trend 0.004), but not younger men (p trend 0.4) or women regardless of age (p trend 0.4 in younger and older women).

Conclusions: These data suggest an inverse association of 25(OH)D with MetSyn, independent of potential confounding factors, calcium intake, and PTH, and a positive association of PTH with MetSyn among older men.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 European Society of Endocrinology.